Upside Coming for Biotech ETFs Against Challenging Political Backdrop

The iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), the largest biotechnology exchange traded fund by assets, is up more than 10% year-to-date and although the behemoth biotech fund has backed off its recent highs, some traders believe more upside is coming for the widely followed sector....
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.